Ibrutinib (Imbruvica®) for the treatment of Waldenstrom's disease
Wijma S, de Boer JE
Record ID 32018001625
Dutch
Original Title:
Package advice ibrutinib in case of Waldenstrom's disease
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/09/14/ibrutinib-imbruvica-for-the-treatment-of-waldenstroms-disease
English language abstract:
An English language summary is available
Publication Type:
Other
Country:
The Netherlands
MeSH Terms
- Waldenstrom Macroglobulinemia
- Tyrosine Kinase Inhibitors
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.